Global Controlled Release Drug Delivery Market Segments 2024, Forecast To 2033
5 Mar, 2024
The controlled release drug delivery market has experienced rapid growth, climbing from $59.2 billion in 2023 to $66.18 billion in 2024, registering a CAGR of 11.8%. This growth is attributed to pioneering drug delivery systems, early polymer-based formulations, and regulatory approvals. Predictions for 2028 estimate a market size of $105.06 billion, driven by a shift towards personalized medicine, technological integration for patient convenience, and advancements in polymer science, maintaining a CAGR of 12.2%. Major trends encompass biodegradable materials and nanotechnology advancements.
Global Controlled Release Drug Delivery Market Key Driver
The rising prevalence of chronic diseases is propelling the controlled release drug delivery market. Chronic diseases, responsible for a significant global mortality rate, require prolonged medical care. Controlled-release drug delivery is crucial for effective treatment. The World Health Organization reports that 74% of global fatalities result from chronic diseases, emphasizing the critical role of controlled release drug delivery in managing chronic conditions.
Get A Free Sample Of The Global Controlled Release Drug Delivery Market ReportGlobal Controlled Release Drug Delivery Market Segments
The controlled release drug delivery market covered in this report is segmented –
1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies
2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,
3) By Application: Metered Dose Inhalers, Injectable, Transdermal and Ocular Patches, Other Applications
4) By End User: Hospitals, Clinics, Peronal, Research, Other End Users
By Geography: The regions covered in the anti inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions.
North America was the largest region in the controlled release drug delivery market in 2023. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Controlled Release Drug Delivery Industry Players
Johnson & Johnson Services Inc.; Merck & Co. Inc.; Alkermes plc; Coating Place Inc.; Corium International Inc.; Depomed Inc.; Pfizer Inc.; Aradigm Corporation; Capsugel LLC; GlaxoSmithKline plc; Bayer Healthcare LLC; Collegium Pharmaceuticals Inc.; GE HealthCare Technologies Inc.; Adare Pharmaceuticals Inc.; Allergan plc; Novartis AG; Lonza Group AG; Colorcon Inc.; SKY Pharmaceuticals Pvt. Ltd.; AstraZeneca plc; Biogen Inc.; Orbis Biosciences Inc.; Alza Corporation; MicroCHIPS Inc.; Endo International plc; Heron Therapeutics Inc.; Intellipharmaceutics International Inc.; Ipsen Biopharmaceuticals Inc.; Luye Pharma Group Ltd.; Medtronic plc; Nektar Therapeutics; Novo Nordisk A/S; Ocular Therapeutix Inc.; Pacira BioSciences Inc.; Progenity Inc.; Sanofi S.A.; Teva Pharmaceutical Industries Ltd.; Titan Pharmaceuticals Inc.; Vectura Group plc; West Pharmaceutical Services Inc.; Zosano Pharma Corporation; Zynerba Pharmaceuticals Inc.
Get The Full Global Controlled Release Drug Delivery Market ReportAIOps Controlled Release Drug Delivery Market Overview
Controlled release drug delivery refers to a dosage form that administers a medicine or medication in a specified way. This drug delivery method continuously delivers pharmaceuticals or medications in predictable kinetics for the predetermined time.
Controlled Release Drug Delivery Global Market Report 2023 provides data on the global controlled release drug delivery market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The controlled release drug delivery market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.